Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance

被引:112
作者
Ayaz, Muhammad [1 ]
Subhan, Fazal [2 ]
Ahmed, Jawad [3 ]
Khan, Arif-ullah [4 ]
Ullah, Farhat [1 ]
Ullah, Ihsan [5 ]
Ali, Gowhar [2 ]
Syed, Nawazish-i-Husain [6 ]
Hussain, Sajid [7 ]
机构
[1] Univ Malakand, Dept Pharm, Khyber Pakhtoonkhwa 18000, Pakistan
[2] Univ Peshawar, Dept Pharm, Peshawar, Pakistan
[3] Khyber Med Univ, IBMS, Peshawar, Pakistan
[4] Riphah Int Univ, Riphah Inst Pharmaceut Sci, Dept Pharmacol, Islamabad, Pakistan
[5] Univ Swabi, Dept Pharm, Swabi, Pakistan
[6] Univ Punjab Lahore, Univ Coll Pharm, Lahore 54000, Pakistan
[7] Kohat Univ Sci & Technol, Dept Pharm, Kohat, Pakistan
关键词
Sertraline; Well assay; Minimum fungicidal concentration; ATCC; SEROTONIN REUPTAKE INHIBITORS; MULTIDRUG EFFLUX PUMP; IN-VITRO; ANTIBIOTICS; RESISTANCE;
D O I
10.1186/s40709-015-0028-1
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Serotonin reuptake inhibitors were recently reported to possess antimicrobial potentials, potentiate activity of several antibiotics, reverse multidrug resistant phenotypes of bacteria and make them susceptible to previously resistant drugs. We investigated antimicrobial potentials of sertraline (SR) against ATCC strains, clinical isolates of Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa alone and in-combination with seven antibiotics. Antifungal activity was investigated against four fungal strains including Aspergillus niger, Aspergillus fumigatus, Aspergillus flavus, and Fusarium solani. Intrinsic antibacterial action and Minimum Inhibitory Concentrations (MICs) were determined using well assay, nutrient broth and agar dilution techniques. Disk diffusion and nutrient broth methods were used to study bacterial susceptibility to SR. Minimum Fungicidal Concentrations (MFCs) of SR were determined using Sabouraud dextrose Agar (SDA). Results: Sertraline possesses strong intrinsic antibacterial, antifungal activities and has augmented the antibacterial activities of antibiotics. For S. aureus ATCC 6538, E. coli ATCC 8739 and P. aeruginosa ATCC 9027, the MICs of SR were 20, 40 and 60 mu g ml(-1), respectively, whereas 55.5% clinical isolates of S. aureus and 50% of E. coli strains were inhibited at 20 and 60 mu g ml(-1) of SR, respectively. Among the tested fungi, 60% of A. niger and A. fumigatus were inhibited at 40 and 80 mu g ml(-1), respectively. MFCs were 60 and 80 mu g ml(-1) for A. flavus and F. solani, respectively. Antibacterial activities of all antibiotics were significantly increased (p < 0.001) with the addition of SR 100 mu g ml(-1) against all tested bacteria. Conclusion: Combination study revealed that SR had significantly increased the activity of antibiotics, and some previously resistant strains were made susceptible. Thus antidepressants are potential sources of resistance modifying agents when used in combination.
引用
收藏
页数:8
相关论文
共 47 条
[1]   A SURVEY OF THE ANTIBACTERIAL ACTIVITY OF SOME NEW-ZEALAND HONEYS [J].
ALLEN, KL ;
MOLAN, PC ;
REID, GM .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1991, 43 (12) :817-822
[2]  
Amaral Leonard, 2004, In Vivo (Attiki), V18, P725
[3]  
[Anonymous], 2012, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically
[4]  
Approved Standard - Ninth Edition
[5]  
[Anonymous], 2003, PERF STAND ANT DISK
[6]   RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine [J].
Bailey, Andrew M. ;
Paulsen, Ian T. ;
Piddock, Laura J. V. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (10) :3604-3611
[7]  
Barrow GI., 1993, COWAN STEELS MANUAL, V3th
[8]   CORRELATIONS BETWEEN METHODS FOR MEASUREMENT OF SYNERGY [J].
BERENBAUM, MC .
JOURNAL OF INFECTIOUS DISEASES, 1980, 142 (03) :476-478
[9]   Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli [J].
Bohnert, Juergen A. ;
Szymaniak-Vits, Magdalena ;
Schuster, Sabine ;
Kern, Winfried V. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (09) :2057-2060
[10]   ANTIBACTERIAL ACTIVITIES OF NON-ANTIBIOTIC DRUGS [J].
CEDERLUND, H ;
MARDH, PA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (03) :355-365